VIVO News and Press, Meridian Bioscience Inc. From 01/04/22

Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference PR Newswire CINCINNATI , Jan. 4, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials,...

Meridian Bioscience (NASDAQ:VIVO) says that its Chief Financial Officer and Executive Vice President Bryan Baldasare is retiring from the company effective Dec. 31, 2021. Baldasare, who joined Meridian (VIVO) in 2000, has served as its CFO since 2019. During his tenure, the company has expand...

Meridian Bioscience Announces Retirement of CFO Bryan Baldasare PR Newswire CINCINNATI , Dec. 2, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announce...

Meridian Bioscience (NASDAQ:VIVO) has announced that David Phillips, Chairman of the Board, will retire from the Board of Directors and not seek re-election when his term ends in Jan. 2022. The Board of Directors will elect a new chair when Mr. Phillips' term expires and will not replace the ...

Meridian Bioscience Announces Retirement of Chairman David Phillips PR Newswire CINCINNATI , Nov. 24, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, ann...

Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing PR Newswire CINCINNATI , Nov. 17, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider...

Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q4 2021 Earnings Call Nov 12, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript

Meridian Bioscience, Inc. (VIVO) Q4 2021 Earnings Conference Call November 12, 2021 10:00 AM ET Company Participants Charles Wood – Vice President of Investor Relations Jack Kenny – Chief Executive Officer Bryan Baldasare – Chief Financial Officer Conference Call Particip...

Meridian Bioscience (NASDAQ:VIVO): Q4 Non-GAAP EPS of $0.23 beats by $0.03; GAAP EPS of $0.15 misses by $0.04. Revenue of $76.2M (+18.8% Y/Y) beats by $7.8M. Shares +0.78% PM. Press Release For further details see: Meridian Bioscience EPS beats by $0.03, beats on revenue

Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance PR Newswire CINCINNATI , Nov. 12, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial r...